To ensure maximum safety, MarketsandMarkets has initiated a mandatory COVID-19 vaccination policy for all in-person attendees across all our physical events. Attendees will be asked to provide proof of vaccination. Additional details on the vaccine policy will be provided upon registration.

Attendees that cannot participate due to this policy, or because of any travel restrictions, are encouraged to participate in the event by registering virtually and attending the event which will be live streamed on our very well appreciated virtual event platform!

These policies may shift as the virus subsides, but we firmly feel this is the right time for MarketsandMarkets to reopen our much awaited physical events safely! We stay committed in our fight against COVID, a variety of new protocols and elevated practices are in place at the venue along with maintaining high standards of cleanliness. We are strictly adhering to the safety guidelines outlined by the Government. We also encourage our participants to review all federal, state, and local permitted traveler guidance before travel and making a reservation.

Leveraging next gen technologies beyond conventional biomarker drug discovery

The 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference scheduled to be held on 16th - 17th June 2022 in San Diego, CA would address the gaps between early stage biomarker development and the commercialization stage of biomarkers.

30+ experts from academia and industry will be presenting their current work in Biomarkers, Latest updates on regulatory guidelines and approvals, Cancer biomarker validation for clinical application, Biomarkers and Personalized Medicine, Impact of Big data in translational biomarker research and Future of Companion Diagnostics

Opportunity to develop long-lasting business relationships and networking opportunities with researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies, Universities, and Research institutes.

Over 20 presentations, round-tables, and panel discussions focused on the key opportunities and challenges in biomarker research, from precision medicine and companion diagnostics through to digital biomarkers and clinical trials.

This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers..